Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Erythrocyte Transfusion | 9 | 2019 | 386 | 2.98 | Why? |
| Erythrocytes | 10 | 2020 | 617 | 2.19 | Why? |
| Blood Preservation | 4 | 2019 | 191 | 0.96 | Why? |
| Rho(D) Immune Globulin | 1 | 2019 | 5 | 0.82 | Why? |
| Erythroblastosis, Fetal | 1 | 2019 | 12 | 0.81 | Why? |
| Transfusion Medicine | 1 | 2019 | 101 | 0.68 | Why? |
| Erythropoiesis | 1 | 2017 | 71 | 0.64 | Why? |
| Phagocytosis | 1 | 2018 | 409 | 0.62 | Why? |
| Iron | 2 | 2017 | 619 | 0.56 | Why? |
| Anemia, Iron-Deficiency | 1 | 2017 | 210 | 0.55 | Why? |
| Anemia | 1 | 2017 | 789 | 0.41 | Why? |
| Blood Donors | 3 | 2020 | 2956 | 0.35 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.32 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.30 | Why? |
| N-Acetylgalactosaminyltransferases | 1 | 2003 | 3 | 0.28 | Why? |
| Blood Grouping and Crossmatching | 2 | 2021 | 125 | 0.27 | Why? |
| Toxoplasma | 1 | 2003 | 61 | 0.26 | Why? |
| Hemolysis | 4 | 2020 | 283 | 0.26 | Why? |
| Gene Library | 1 | 2003 | 234 | 0.25 | Why? |
| Hemagglutination Tests | 1 | 2002 | 124 | 0.22 | Why? |
| Membrane Lipids | 1 | 2020 | 91 | 0.21 | Why? |
| Chromium Radioisotopes | 1 | 2019 | 3 | 0.20 | Why? |
| Cloning, Molecular | 1 | 2003 | 1036 | 0.20 | Why? |
| CD59 Antigens | 1 | 2019 | 9 | 0.20 | Why? |
| Kynurenine | 1 | 2020 | 140 | 0.19 | Why? |
| Cell Death | 2 | 2019 | 536 | 0.19 | Why? |
| Fatty Acids | 1 | 2020 | 238 | 0.19 | Why? |
| Hypoxanthine | 1 | 2017 | 5 | 0.18 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2002 | 556 | 0.18 | Why? |
| Cell Division | 1 | 2018 | 136 | 0.18 | Why? |
| Lipid Peroxidation | 1 | 2018 | 114 | 0.18 | Why? |
| Sweat | 1 | 2019 | 127 | 0.18 | Why? |
| Erythrocyte Aging | 1 | 2017 | 13 | 0.17 | Why? |
| Complement System Proteins | 1 | 2020 | 380 | 0.16 | Why? |
| Blood Proteins | 1 | 2020 | 551 | 0.16 | Why? |
| Necrosis | 1 | 2019 | 532 | 0.15 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.13 | Why? |
| Proteome | 2 | 2020 | 1812 | 0.13 | Why? |
| Mice | 5 | 2019 | 21357 | 0.12 | Why? |
| Mice, Inbred C57BL | 3 | 2019 | 5542 | 0.12 | Why? |
| Renal Insufficiency | 1 | 2020 | 810 | 0.12 | Why? |
| History, 20th Century | 1 | 2019 | 1282 | 0.12 | Why? |
| Personnel Selection | 1 | 2019 | 512 | 0.12 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.12 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.11 | Why? |
| ABO Blood-Group System | 1 | 2021 | 995 | 0.11 | Why? |
| Purines | 1 | 2017 | 816 | 0.11 | Why? |
| Animals | 7 | 2019 | 78931 | 0.11 | Why? |
| Immunization, Passive | 6 | 2021 | 10067 | 0.10 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.10 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.10 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.10 | Why? |
| Oxidative Stress | 1 | 2020 | 2050 | 0.09 | Why? |
| Molecular Sequence Data | 2 | 2003 | 3198 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Metabolome | 2 | 2020 | 624 | 0.08 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.07 | Why? |
| Humans | 23 | 2021 | 930598 | 0.07 | Why? |
| Blood Banks | 2 | 2019 | 535 | 0.06 | Why? |
| Hypoxia | 1 | 2017 | 3626 | 0.06 | Why? |
| Chromatography, Gel | 1 | 2002 | 71 | 0.06 | Why? |
| Recombinant Proteins | 2 | 2003 | 3786 | 0.06 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 238 | 0.06 | Why? |
| Substrate Specificity | 1 | 2003 | 639 | 0.06 | Why? |
| Cystine | 1 | 2020 | 12 | 0.06 | Why? |
| Health Services Needs and Demand | 1 | 2016 | 3419 | 0.06 | Why? |
| Polyamines | 1 | 2020 | 44 | 0.05 | Why? |
| Amino Acid Sequence | 2 | 2003 | 6049 | 0.05 | Why? |
| Investigational New Drug Application | 1 | 2020 | 75 | 0.05 | Why? |
| Methionine | 1 | 2020 | 53 | 0.05 | Why? |
| Indicators and Reagents | 1 | 2002 | 183 | 0.05 | Why? |
| Creatine | 1 | 2020 | 66 | 0.05 | Why? |
| Dimerization | 1 | 2002 | 475 | 0.05 | Why? |
| Fatty Acids, Nonesterified | 1 | 2020 | 60 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Technetium | 1 | 2019 | 21 | 0.05 | Why? |
| DNA, Complementary | 1 | 2002 | 568 | 0.05 | Why? |
| Blood Transfusion, Autologous | 1 | 2019 | 37 | 0.05 | Why? |
| Glycosylation | 1 | 2003 | 1255 | 0.05 | Why? |
| Tryptophan | 1 | 2020 | 218 | 0.05 | Why? |
| Deamination | 1 | 2017 | 18 | 0.05 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| Plasmapheresis | 1 | 2021 | 437 | 0.04 | Why? |
| Sequence Alignment | 1 | 2003 | 2109 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2020 | 801 | 0.04 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.04 | Why? |
| Antibody Affinity | 1 | 2002 | 1078 | 0.04 | Why? |
| Adenosine Triphosphate | 1 | 2019 | 294 | 0.04 | Why? |
| Amino Acids | 1 | 2020 | 552 | 0.04 | Why? |
| Blotting, Western | 1 | 2019 | 863 | 0.04 | Why? |
| Proteolysis | 1 | 2020 | 751 | 0.04 | Why? |
| Rats | 1 | 2003 | 2764 | 0.04 | Why? |
| Phosphorylation | 1 | 2019 | 1060 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Spleen | 1 | 2019 | 877 | 0.04 | Why? |
| Genetic Vectors | 1 | 2002 | 1600 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2003 | 2830 | 0.03 | Why? |
| Metabolomics | 1 | 2020 | 921 | 0.03 | Why? |
| Escherichia coli | 1 | 2002 | 1547 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2019 | 1136 | 0.03 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2019 | 2739 | 0.03 | Why? |
| Gene Expression | 1 | 2002 | 3332 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Membrane Proteins | 1 | 2020 | 1733 | 0.03 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.02 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.02 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.02 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2003 | 6740 | 0.02 | Why? |
| Apoptosis | 1 | 2019 | 2335 | 0.02 | Why? |
| Cells, Cultured | 1 | 2019 | 5835 | 0.02 | Why? |
| New York City | 1 | 2021 | 7432 | 0.02 | Why? |
| Research | 1 | 2020 | 2115 | 0.02 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Models, Molecular | 1 | 2020 | 7616 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 7868 | 0.02 | Why? |
| Blood Glucose | 1 | 2020 | 3642 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Liver | 1 | 2019 | 4007 | 0.02 | Why? |
| Developing Countries | 1 | 2020 | 4283 | 0.02 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.02 | Why? |
| Brazil | 1 | 2021 | 12582 | 0.02 | Why? |
| Antibodies, Viral | 3 | 2020 | 51949 | 0.02 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Male | 4 | 2021 | 367725 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
Spitalnik's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(164)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_